To evaluate the optimal discriminators for peripheral atherosclerosis, we studied retrospectively 49 male patients and 39 male controls between 40 and 60 years of age. In addition to hypertension, cigarette smoking, diabetes mellitus, and hyperuricemia, we determined the most common tipids, lipoproteins, and apolipoproteins. Highly significant differences of median values between patients and controls in decreasing order of magnitude were recorded for apo A-ll/apo B, apo A-l/apo B, apo B, total cholesterol, and LDL-cholesterol. A retrospective classification of patients and controls under optimal conditions with one variable (apo A-l/apo B) yielded an error rate of 25%. We found that apolipoproteins were better discriminators for peripheral atherosclerosis than were liplds or lipoprotein lipids. The application of a linear regression discriminant analysis including all 29 variables greatly decreased the rate of error and increased the sensitivity and specificity of the classification. From 2 29 possible models, we used an economic selection strategy to sort out those which either gave the best segregation or were considered the most practicable. The optimal model with 14 variables gave an error rate of less than 5% for the group studied. Suboptimal models yielded error rates between 13% and 18%. We conclude that a mathematical treatment of laboratory data which includes lipid parameters in addition to apolipoprotein values can improve the classification of peripheral vascular atherosclerosis.
T he significance of lipid and lipoprotein levels in atherogenesis is well established. 1 " 3 Studies have shown that patients suffering from peripheral vascular disease (PVD) had increased serum concentrations of triglycerides, total cholesterol, 45 low density lipoprotein cholesterol (LDL-C), 67 apolipoprotein B (apo B), 8 and very low density lipoprotein (VLDL)-apo B. 9 By contrast, high density lipoprotein VLDL-apo B/VLDL-C. 9 In this and other studies, however, there were no calculations on related subjects concerning specificity, sensitivity, or rate of misclassification using one or several parameters as discriminators. In this report we tried to find out which single parameter might best reflect peripheral atherosclerosis. In addition, various risk indicators were treated in a multiple regression analysis with dummy variables and several discriminant models were calculated. We here report on those which we considered as optimal or suboptimal in terms of sensitivity, specificity, and practicability. Table 1 lists some characteristics of our patients and controls. Patients selected for this study represented a consecutive series of subjects referred to the outpatient center of angiology at the University Hospital in Graz. All were outpatients and referred by various physicians between July and December, 1981, because of intermittent claudication. The diagnosis of peripheral vascular disease was based on the results of Doppler ultrasound examination followed by angiography. Eleven patients were classified as Stage 1 and 38 patients, as Stage 2 according to Fontaine's criteria. 21 The controls were selected randomly from individuals referred to the outpatient clinic of the Department of Internal Medicine at the University Hospital for a medical checkup. In this control group, PVD was excluded by measuring systolic blood pressure by ultrasound examination of the ankle arteries after a standardized exercise test. 22 CVD was excluded by an electrocardiograph examination after an exercise test. Individuals showing pathologic peripheral vascular function without PVD symptoms were put into the patient group.
Methods

Study Patients and Controls
The criteria for inclusion as a subject were that the person be a male between 40 and 60 years of age; that he have Stage 1 PVD without any clinical symptoms or Stage 2 PVD with intermittent claudication diagnosed for the first time (the first clinical symptom had occurred within the past 6 months and there had been no specific therapy).
The criteria for exclusion were: diagnosis of any disease that causes a lipid or lipoprotein alteration (such as liver, thyroid, renal, or endocrine disease); any therapy known to affect serum lipid and lipopro-tein concentration; diagnosis of a malignant disease; chronic alcoholism; any condition necessitating confinement to bed; regular physicial training (such as jogging); PVD caused by inflammation; and uncontrolled diabetes mellitus.
The average duration of diabetes mellitus in the patient group was 4 years (ranging from 1 to 7 years); in the control group the duration was 4.5 years (ranging from 3 to 6 years). Each subject was seen regularly at the outpatient clinic of the Department of Internal Medicine at the University Hospital of Graz. During the past 2 years, the Hb-A^C levels in diabetic subjects, examined five times a year, were less than 11%, except in four patients. In these patients, three were taking an oral antidiabetic medicine and one, insulin. The Hb-A,-C levels were greater than 11 % six times. Nine diabetic subjects from the PVD group showed diabetic retinopathy in Stage 1, and two subjects, in Stage 2.
Hypertension (systolic BP greater than 150 mm Hg, diastolic BP greater than 100 mm Hg), diabetes mellitus (fasting blood glucose greater than 120 mg/dl), hyperuricemia (uric acid/serum greater than 7.0 mg/dl) and smoking more than five cigarettes a day were recorded as discrete parameters and considered as risk factors.
Chemical Analysis
All laboratory data were obtained after the individuals had fasted for 12 to 14 hours. Serum concentrations of triglycerides, total cholesterol, and HDL cholesterol were determined enzymatically using assays from Boehringer Mannheim (Mannheim, West Germany). Very low density lipoproteins were removed by ultracentrifugation at serum density for 18 hours at 1.2 x 10 s g at 15°C. Cholesterol was measured in the bottom fraction (LDL-C + HDL-C) and LDL-C was obtained after subtracting HDL-C, taking into consideration changes of volume. The apolipoproteins were measured by radial Immunodiffusion. 23 Apo B and apo A were determined with partigen plates from Behringwerke (Behringwerke AG, Marburg/Lahn, West Germany) using the appropriate Behring tables for calculation. Apo B was determined after removal of VLDL in the ultracentrifugation or, like apo A, from total serum. According to Behringwerke, apo A is considered as the apolipoprotein content of HDL, presumably the sum of apo A-l and A-ll. Apo A-l and A-ll were quantified also by the Mancini technique 24 ' a using our own monospecific antisera. To expose all antigenic determinants, we incorporated 2% Triton-X100 into the antibody containing agarose gel. 26 The standard from Immuno (Immuno AG, Vienna, Austria) was used for calculating absolute amounts. This standard gave similar results to our standard from previous studies, but was selected for practical purposes.
Statistical Methods
Since the distribution of some variables and quotients deviated strongly from a normal distribution, the means of the groups were compared by a Wilcoxon rank sum test assuming that the rank sum is normally distributed. For every variable, a cut-off point x (c) was determined according to the criterion so that the error rate (sum of false positives and false negatives in percentages) became a minimum.
A stepwise linear discriminant analysis was performed to achieve a better classification of the individuals from more than one parameter. To get a better approximation to a normal distribution for variables with extreme values, we performed transformations, e.g., x(--logx). After these transformations, there were smaller deviations from a normal distribution. The linear discriminant function was robust when the distribution did not deviate markedly from normal. 27 For model identification, a parameter selection procedure analogous to multiple regression analysis was used. This procedure is based on the t-value of the coefficients and the Cp statistic. 28 It is a combination of forward and backward stepwise regression. For the selection of the best discriminant function, the t-value, the error rate, sensitivity, and specificity were used. 29 By using the linear discriminant function, we tried to sort out those variables which gave the weakest segregation in combination with each other. We calculated the data in two ways: 1) considering only lipids and lipoproteins; and 2) including the transformed data of lipids and lipoproteins as well as the discrete variables. Table 2 lists the median values of the parameters we investigated in addition to individually calculated ratios from PVD patients and controls. Considering the listed cutoff points, we found that many medians of the variables and the ratios were significantly different in patients as compared to controls. The variables with the highest significance (see z values) in a decreasing order of magnitude were: apo A-ll/apo B, apo A-l/apo B, apo B, and total cholesterol. HDL-C by itself did not significantly differ between patients and controls. By retrospective classification of all subjects, apo A-l/apo B and apo A-ll/apo B were also the variables with the lowest rate of error (table 2) . The cumulative frequency distributions of LDL-C/ HDL-C ratio and apo A-l/apo B ratio are illustrated in figure 1 .
Results
Out of all our models, we have listed in table 3 only those which we considered as optimal or suboptimal with respect to the discriminative value for PVD. In Model A it was possible to reach an error rate of 21.3% by considering the apo B, apo A-l and apo A-ll data (table 3, Model A-l). The cumulative frequency distribution of y values of this model is shown in figure 2 A. Although this result of Model A-l could be improved further by adding other parameters, such as total cholesterol, LDL-C, HDL-C, apo A, and LDLapo B or by respecting some ratios, we considered this not feasible from a practical point of view. The minimal error rate that could be reached was 13.4% (table 3, Model A-ll). In Model B the transformed data and the discrete parameters were included in the calculation and an additional improvement of the discriminant power was reached. Including all 29 variables, the error rate dropped to 6.7%. Reducing the number of parameters to the 14 listed in table 3 resulted in an error rate of 4.4% and a sensitivity/specificity of 0.94 in Model B-lll. We considered Model B-lll as optimal in respect to practicality, precision, and discriminative power (figure 2 B) . It should be mentioned, however, that by using only those laboratory parameters that are usually determined (total cholesterol, LDL-C, HDL-C, apo B, and apo A-l) in combination with discrete parameters (cigarette smoking and diabetes mellitus), it was possible to reach an error rate of 18%, a sensitivity of 76%, and a specificity of 89% (table 3, Model B-ll). We considered this model to be suboptimal.
Discussion
In this study estimating the risk for a given disease by considering the significance of the differences between the mean of median values of the patients and the controls resulted in total cholesterol, LDL-C, and apo B being the most serious positive risk factors for PVD. Among the "negative" risk factors for atherosclerosis, we found only apo A-ll a significant parameter. Our results were similar to those reported by Whayne et al. 18 and Riesen et al. 17 in patients with CVD, as well as to the results of Franceschini et al. 9 in PVD patients in that we found no significant difference in HDL-C between PVD patients and controls.
The "atherosclerosis index" (LDL-C/HDL-C), which has been considered the most prominent discriminator for atherosclerosis, 20 ' x was found to be significant in our study, but far less so than other parameters such as apo A-l/apo B, apo A-ll/apo B, or apo B (table 2) . Furthermore, the discriminative value of apo A-l/apo B was much better than LDL-C/ HDL-C ( figure 1) . Thus, we believe that apolipoprotein levels, in fact, reflect the risk for peripheral vascular disease much better than do lipid or lipoprotein levels. Despite the quite high significance of calculated differences of median values between patients and controls, it is important to be aware that the number of false-positive and false-negative estimates depends on the individual cut-off points chosen.
Nevertheless, we made a mistake in every fourth case by using the best parameter for classifying all individuals of this study retrospectively. Using the LDL-C/HDL-C ratio as a discriminative parameter, we misclassified every third subject. By mathematically connecting several variables after the application of the linear discriminant analysis, we had far better results. Selecting optimal models in an economic way according to Pfeiffer et al. 28 out of 2 28 theoretical possibilities yielded a variety of combinations whereby up to 95% of the individuals investigated were classified correctly. Further investigation will determine whether similar results can be obtained by studying other collectives. During the parameter selection process that we used in this study, some very significant parameters (discriminators) may have been sorted out or have lost priority; however, they could be replaced by ratios or logarithms of a previously unimportant variable. An improvement of a given model could also be achieved by including variables which correlated to each other. On the other hand, adding parameters could cause an increase of false information in regard to the discrimination of the subjects, and therefore an increase in the error rate. The application of a stepwise discriminant analysis allowed us to find out those combinations of variables that exhibited the most powerful discriminatory power.
To obtain the so-called y value, we multiplied each remaining parameter by a factor according to its potency and added it to the others. 28 ' w In this study we chose a cut-off point for y according to a minimal rate of error. To achieve a maximum in the positive predictive value or a minimum in the negative predictive value, the cut-off point of y must be changed to the left or to the right (figures 1 A-2 B) . De Baker et al. 31 reported a classification of survivors of myocardial infarction and controls which was 82% correct by using a similar discriminant analysis.
We found a minimum rate of error in Model B-III. On the other hand, Model B-l was superior for the best segregation of mean values. By comparing Model A with Model B it became evident that not only the discrete parameters, but also the log transformation of those parameters (whose values deviated most from the normal distribution) added significantly to the discriminatory power. This was valid also for the improvement of the rate of error and for segregation.
The apo A-l to apo B or the apo A-ll to apo B ratios were a component of all the calculated models and were never sorted out. Thus, these ratios must be considered as the most prominent discriminators for PVD. Avogaro et al. 18 reported that the apo A-l to apo B ratio was the best discriminator of postmyocardial infarction; De Baker et al. 31 reported that the apo B to apo A-l ratio was the best discriminator. Nevertheless, in no case were the optimal models achieved by apolipoprotein values alone. Including total cholesterol, LDL-C, and HDL-C doubtless greatly improved predictive power.
We are certainly aware of some of the drawbacks of this type of study. First, it would be desirable to investigate these "risk" or "antirisk" factors in a longterm prospective study to differentiate between factors that cause the disease and those that are a result of it. Thus we consider the present report as a preliminary basis for further studies. Second, 40% of the PVD patients suffered from diabetes mellitus, whereas in the control group there were only 5% with diabetes. It has been shown that diabetes mellitus is connected with disturbances of lipoprotein metabolism and with altered serum values of apolipoproteins. 32 ' w In our group of PVD patients, however, we found no significant differences in mean values of any laboratory parameter except apo A-ll. Further, when we sorted out all the patients and controls with diabetes mellitus, we observed that apo A-ll and apo A-ll/apo B were still significant parameters. Only apo A-ll correlated significantly with diabetes mellitus in our study. We thus may assume that diabetes mellitus leads to lipid and lipoprotein alterations that are characteristic of PVD patients and may have other, as yet unknown, causes. Finally, we know, that the number of subjects studied was not very great. In that respect, it must be stated that we arrived at similar or identical models quite early when this study was only half completed. Thus, increasing the number of patients and controls may not necessarily alter the model type (e.g., the content of the parameters) but the significance improves and the variance of the estimated model parameters can be decreased.
